1447P Nal-IRI/LV5-FU Versus Paclitaxel As Second-Line Therapy in Patients with Metastatic Esophageal Squamous Cell Carcinoma (OESIRI-PRODIGE 62): A FFCD Multicenter, Randomized, Phase II Study
Annals of Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined